Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Jumia Technologies AG - ADR (JMIA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Jumia Technologies AG - ADR — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B), while Jumia Technologies AG - ADR trades at $5.72 (market cap $789.73M). The key difference: Hinge Health Inc. Class A Common Stock is far larger — about 10.7× Jumia Technologies AG - ADR's market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Jumia Technologies AG - ADR nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Jumia Technologies AG - ADR for 29 Days on average.
| HNGE | JMIA | |
|---|---|---|
Market Cap | $8.48B | $789.73M |
Volume | 879,799 | 1,367,204 |
Sector | Health | Consumer Cyclical |
52-Week High | $105.14 | $14.60 |
52-Week Low | $31.17 | $5.69 |
Typical Hold Time | 0 Days | 29 Days |
Enterprise Value | $8.10B | $755.37M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
JMIA stock trades at $5.79, down 5.24% on the day, amid a bearish technical outlook with all moving averages signaling sell. Fundamentally, the company reported a net loss of $61.55 million in 2025, though revenue grew to $188.93 million and the net loss margin improved to -32.58%. Recent news highlights a $50 million capital raise and progress toward EBITDA breakeven by year-end 2026, per company reports from August 2026.
The outlook is mixed: analyst consensus is bullish with a $12 price target, but high execution risks persist given persistent losses and negative ROE. Investors face volatility from operational cash burn and competitive pressures in African e-commerce, though cost controls and growth initiatives offer potential upside if profitability targets are met.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Jumia Technologies AG - ADR
Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace, which connects sellers with consumers. Its logistics service enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. Jumia generates revenue from Sales of goods, Commissions, Fulfillment, Value-added services, and Marketing & Advertising. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates most of its revenue from the West Africa segment.
Read more on JMIA →
